by Raynovich Rod | Apr 22, 2025 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools
Update-3 …ABBVIE (ABBV) beat with adj. EPS 2.46 earnings and revenues of $13.343B an increase of 4%, but tariff issues lurking,,, I$10M investments will be made in U.S. Strong sales $6.264B of new immunology drugs Rinvoq and Skirizi an increase of 16.6%. EPS...
by Raynovich Rod | Feb 28, 2013 | BIOgraph
Market Reverses Late in the Day Giving Pause to Euphoria Intuitive Surgical (ISRG $509.89) plunged 11% in final minutes upon disclosure from Bloomberg of a safety probe from U.S. regulators. An FDA survey is trying to determine “whether adverse incident reports...
